Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
about
Role of microglia in central nervous system infectionsMicroglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In VivoThe neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseasesUse of laser microdissection in the investigation of facial motoneuron and neuropil molecular phenotypes after peripheral axotomyVIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 miceVasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders.Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release.Enhanced virulence, airway inflammation and impaired lung function induced by respiratory syncytial virus deficient in secreted G proteinPain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions.Tuning inflammation with anti-inflammatory neuropeptides.PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity.Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosisNeuropeptides as pleiotropic modulators of the immune response.The role of regulatory T cells in neurodegenerative diseases.Effect of PACAP in central and peripheral nerve injuries.Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression.Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative DiseasesPituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.The inflammatory response to silver and titanium dioxide nanoparticles in the central nervous system.The effect of titanium dioxide nanoparticles on neuroinflammation response in rat brain.The change of plasma pituitary adenylate cyclase-activating polypeptide levels after aneurysmal subarachnoid hemorrhage.The effects of Fructus Aurantii extract on the 5-hydroxytryptamine and vasoactive intestinal peptide contents of the rat gastrointestinal tract.Molecular mechanisms underlying the Nephroprotective effects of PACAP in diabetes.
P2860
Q24563024-B73F3275-B131-442D-8866-D27409702E31Q26798185-ABE4066F-1C05-4744-8794-52D4AF85A9CAQ26851670-B4E6F551-78BA-4A66-999F-DB98ED626ADCQ33613350-C6E4E580-1B4D-40D7-95A3-D5D977900DB4Q34157261-0B68D119-1E44-4AF9-9B9F-40AA9A8BB4DEQ34238010-D4355C49-F7E6-45B9-907E-2B1B36D1C2C3Q34259060-A4CA2066-3C33-41EC-996D-8CA44036632AQ34542229-B5F4BDDE-48A2-4C3D-83C5-04633A5C04EBQ35107951-492DF0E3-8D3A-476C-843F-483E09486348Q35536713-69493974-358E-4FC8-AB20-98EF152CD2AEQ36515510-FBAFC067-51F4-4615-9B85-34C1245A7C0AQ36764912-540A9F4E-8ED5-4C0D-9EBF-CFB7A2B8EA3FQ36942673-C94255ED-DA02-4CEA-ACCC-64B5782B4842Q37191369-BC0631E2-39F7-4983-A47C-BFFC3425E0C8Q37640081-BA2C8668-0CC3-4C4A-9580-8E4B43D65833Q37898396-CF027282-60C6-4EA1-AEE8-080A01A71165Q38035240-2592B90E-5E17-4D7E-A346-2DCE42DD144AQ38040105-3896941A-C4F7-40F6-94B0-2A3A71EFF46AQ38354522-A5FBEB8C-2345-491A-ADAA-835D228716BBQ39116758-22E69EDC-1865-41DF-A36B-D67533E68BE4Q40462711-6B2B5C93-91C4-4E29-92E8-7E303D771C48Q46249055-A3B77DA3-5179-4126-98A5-B2DC3B415FDEQ46734667-6B8D5C1D-C63A-40CE-B6F4-337BA27177D1Q52147891-84740C64-204D-4546-8F49-F831848817BEQ53580701-56EA8C6D-E838-4671-A2B3-BC50FFBCBF9FQ54376552-EDFEC310-6034-4D73-A539-76B21B813778
P2860
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Vasoactive intestinal peptide ...... uction in activated microglia.
@en
Vasoactive intestinal peptide ...... uction in activated microglia.
@nl
type
label
Vasoactive intestinal peptide ...... uction in activated microglia.
@en
Vasoactive intestinal peptide ...... uction in activated microglia.
@nl
prefLabel
Vasoactive intestinal peptide ...... uction in activated microglia.
@en
Vasoactive intestinal peptide ...... uction in activated microglia.
@nl
P2860
P356
P1433
P1476
Vasoactive intestinal peptide ...... uction in activated microglia.
@en
P2093
Doina Ganea
G Miller Jonakait
P2860
P304
P356
10.1002/GLIA.10098
P577
2002-08-01T00:00:00Z